January Therapeutics, Inc. — Form D/A
January Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2019-02-15. The offering totals $1.4M, of which $1.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-02-15
- Form: D/A
- Accession: 0001708145-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.2M
- Remaining: $200K
- Investors: 13
- Date of first sale: 2019-01-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-331067
Issuer
- Name: January Therapeutics, Inc.
- CIK: 0001708145
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 11575 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO, CA, 92121
- Phone: 858-255-0682
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Samuel Ellis | Director | Dallas, TX |
| Robin Jackman | Director | San Diego, CA |
| Jason Kahana | Director | San Diego, CA |
| David Mizrahi | Director | San Diego, CA |
| Robin Jackman | Executive Officer | San Diego, CA |
| Jason Kahana | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More